Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Chapter 8 - Winners Take All

  • from Section 2 - The Financial Determinants of Discovery
  • Mark P. Khurana, University of Copenhagen
  • Book:
    The Trajectory of Discovery
    Published online:
    06 April 2023
    Print publication:
    13 April 2023, pp 43-50

  • Summary

    Chapter 8 is concerned with why research funds are concentrated among a select few researchers and disease groups, as well as how the concentration of funds influences the rate and direction of research. This concentration is also known as the Matthew Effect or rich-get-richer, and is often a result of biases in funding. The groups that are under-represented will tend to continue to be biased against, resulting in a systematic dearth in their participation and an accumulation of resources among a select few. The benefit of a greater dispersal of funds is that it increases the number of different perspectives actively participating in the creation of scientific knowledge, including the ability of younger researchers to participate. The latter part of the chapter investigates how and why certain disease groups such as diabetes and cancer receive more resources than others, and how this affects the trajectory. The chapter concludes with potential solutions to counteract this clustering of resources on both the individual and disease level.